Drug Shortage Report for ROCURONIUM BROMIDE INJECTION
Report ID | 12130 |
Drug Identification Number | 02318415 |
Brand name | ROCURONIUM BROMIDE INJECTION |
Common or Proper name | ROCURONIUM |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ROCURONIUM BROMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 X 5ML VIALS |
ATC code | M03AC |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-06-09 |
Actual start date | |
Estimated end date | 2017-06-30 |
Actual end date | 2017-07-21 |
Shortage status | Resolved |
Updated date | 2017-10-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-10-10 | French | Compare |
v4 | 2017-10-10 | English | Compare |
v3 | 2017-06-10 | English | Compare |
v2 | 2017-06-06 | French | Compare |
v1 | 2017-06-06 | English | Compare |
Showing 1 to 5 of 5